« Previous Next » Brachytherapy
Volume 7, Issue 4 , Pages 297-300 , October 2008

Inter-institutional variation of implant activity for permanent prostate brachytherapy

Jesse N. Aronowitz
- Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA
- Corresponding author. Department of Radiation Oncology, University of Massachusetts Medical School, Levine Cancer Center, 33 Kendall Street, Worcester, MA 01605. Tel.: +1-508-334-6550; fax: +1-508-334-5624.
Juanita M. Crook
- Department of Radiation Oncology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
- Department of Radiation Medicine, Princess Margaret Hospital, Toronto, ON, Canada
Jeff M. Michalski
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO
John E. Sylvester
- Seattle Prostate Institute, Seattle, WA
Gregory S. Merrick
- Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, WV
Christie Mawson
- Department of Radiation Medicine, Princess Margaret Hospital, Toronto, ON, Canada
David Pratt
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO
Devi Naidoo
- Seattle Prostate Institute, Seattle, WA
Wayne M. Butler
- Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, WV
Kathryn Karolczuk
- Quality Assurance Review Center, Providence, RI

Received 12 February 2008 ,Revised 29 June 2008 ,Accepted 18 July 2008.

References

Yu Y, Anderson LL, Li Z, et al. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. Med Phys. 1999;26:2054–2076
- MEDLINE
- CrossRef
Nag S, Bice W, DeWyngaert K, et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 2000;46:221–230
Salembier C, Lavignini P, Nickers P, et al. Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol. 2007;83:3–10
Yu Y, Waterman FM, Suntharalingham N, et al. Limitations of the minimum peripheral dose as a parameter for dose specification in permanent I-125 prostate implants. Int J Radiat Oncol Biol Phys. 1996;34:717–725
Bice WS, Prestidge BR, Grimm PD, et al. Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy. Int J Radiat Oncology Biol Phys. 1998;41:921–927
Merrick GS, Butler WM, Wallner KE, et al. Variability of prostate brachytherapy preimplant dosimetry: a multi-institutional analysis. Brachytherapy. 2004;4:241–251